Apolipoprotein E ε4 in bulbar-onset motor neuron disease [7]

Lancet

Volumn 348, Issue 9023, 1996, Pages 334-335

  Smith, R G ^a   Haverkamp, L J ^a   Case, S ^a   Appel, V ^a   Appel, S H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; ALLELE; ALZHEIMER DISEASE; DISEASE COURSE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MOTOR NEURON DISEASE; ONSET AGE; PRIORITY JOURNAL; SURVIVAL; COMPARATIVE STUDY; GENETICS; MIDDLE AGED;

ADULT; AGE OF ONSET; ALLELES; APOLIPOPROTEINS E; GENOTYPE; HUMANS; MIDDLE AGED; MOTOR NEURON DISEASE;

EID: 0029666061     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64502-3     Document Type: Letter

References (5)

1. A Al-Chalabi ZE Enayat MC Bakker Association of apolipoprotein E ε4 allele with bulbar-onset motor neuron disease Lancet 347 1996 159 160
2. S Mui GW Rebeck D McKenna-Yasek Apolipoprotein E ε4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis Ann Neurol 38 1995 460 463
3. L Buee J Perez-Tur B Levengle Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes Acta Neuropathol 91 1996 247 253
4. LJ Haverkamp V Appel SH Appel Natural history of amyotrophic lateral sclerosis in a database population: validation of a scoring system and a model for survival prediction Brain 118 1995 707 719
5. EC Lai K Felice BW Festoff A double blind, placebo-controlled study of recombinant human insulin-like growth factor-I in the treatment of amyotrophic lateral sclerosis Ann Neurol 38 1995 971